LncRNA | MiRNA | Gene | Gene name | Pathway Name | Description | Title | Disease/Tissue | Journal | PubMed ID |
ROR | miR-145 | p53 | TP53;BCC7;LFS1;P53;TRP53 | details
MAPK signaling pathway;Cell cycle;Epstein-Barr virus infection;p53 signaling pathway;PI3K-Akt signaling pathway;Apoptosis;Thyroid cancer;Melanoma;Basal cell carcinoma;Measles;Chronic myeloid leukemia;Wnt signaling pathway;Neurotrophin signaling pathway;HTLV-I infection;Non-small cell lung cancer;Proteoglycans in cancer;Prostate cancer;Amyotrophic lateral sclerosis (ALS);Transcriptional misregulation in cancer;Pathways in cancer;Pancreatic cancer;Huntington's disease;Hepatitis C;Colorectal cancer;Glioma;Bladder cancer;Endometrial cancer;Hepatitis B;Viral carcinogenesis;Small cell lung cancer;Herpes simplex infection
|
details
Activity of the p53/miR-145 pathway may help explain the role of lincRNA-ROR for stress-induced regulation in CRC therapy.
|
details
The long noncoding RNA-ROR promotes the resistance of radiotherapy for human colorectal cancer cells by targeting the p53/miR-145 pathway
|
Colorectal Cancer | J Gastroenterol Hepatol | 27696511 |
H19 | miR-675 | p53 | TP53;BCC7;LFS1;P53;TRP53 | details
MAPK signaling pathway;Cell cycle;Epstein-Barr virus infection;p53 signaling pathway;PI3K-Akt signaling pathway;Apoptosis;Thyroid cancer;Melanoma;Basal cell carcinoma;Measles;Chronic myeloid leukemia;Wnt signaling pathway;Neurotrophin signaling pathway;HTLV-I infection;Non-small cell lung cancer;Proteoglycans in cancer;Prostate cancer;Amyotrophic lateral sclerosis (ALS);Transcriptional misregulation in cancer;Pathways in cancer;Pancreatic cancer;Huntington's disease;Hepatitis C;Colorectal cancer;Glioma;Bladder cancer;Endometrial cancer;Hepatitis B;Viral carcinogenesis;Small cell lung cancer;Herpes simplex infection
|
details
Ectopic expression of H19 significantly increased bladder cancer cell proliferation and miR-675 expression in vitro. Furthermore, overexpression of miR-675 promoted bladder cancer cell proliferation, while suppression of miR-675 induced G1 phase cell cycle arrest and promoted cell apoptosis. Western blotting analysis further identified that miR-675 inhibited p53 activation, decreased the ratio of Bax/Bcl-2 and cyclin D1 expression in bladder cancer cells; those effects may result in the abnormal proliferation of bladder cancer cells.
|
details
H19-derived miR-675 contributes to bladder cancer cell proliferation by regulating p53 activation
|
Bladder Cancer | Tumour Biol | 26198047 |
NRF | miR-873 | p53 | TP53;BCC7;LFS1;P53;TRP53 | details
MAPK signaling pathway;Cell cycle;Epstein-Barr virus infection;p53 signaling pathway;PI3K-Akt signaling pathway;Apoptosis;Thyroid cancer;Melanoma;Basal cell carcinoma;Measles;Chronic myeloid leukemia;Wnt signaling pathway;Neurotrophin signaling pathway;HTLV-I infection;Non-small cell lung cancer;Proteoglycans in cancer;Prostate cancer;Amyotrophic lateral sclerosis (ALS);Transcriptional misregulation in cancer;Pathways in cancer;Pancreatic cancer;Huntington's disease;Hepatitis C;Colorectal cancer;Glioma;Bladder cancer;Endometrial cancer;Hepatitis B;Viral carcinogenesis;Small cell lung cancer;Herpes simplex infection
|
details
Further, we identify that p53 transcriptionally activates NRF expression. P53 regulates cardiomyocytes necrosis and myocardial I/R injury through NRF and miR-873.
|
details
The long noncoding RNA NRF regulates programmed necrosis and myocardial injury during ischemia and reperfusion by targeting miR-873
|
Cardiovascular Diseases | Cell Death Differ | 27258785 |